**🚨 Zydus Lifesciences Sets Up New US Subsidiary Amid Global Restructuring Move**

Zydus Lifesciences has incorporated a wholly owned subsidiary in the United States named **Zara Merger SUB Inc.** **Key Details 👇** ✅ New entity incorporated on April 24, 2026 ✅ 100% owned by Zydus Lifesciences ✅ Incorporated in the United States ✅ Pharma sector entity ✅ Purpose: Internal group restructuring The company clarified that the subsidiary is newly formed and currently has nil turnover, as operations are yet to begin. Zydus also mentioned that the investment is being made entirely in cash through subscription to the subsidiary’s share capital. **Why this matters:** US restructuring entities are often created ahead of acquisitions, mergers, pipeline expansion, or strategic operational changes. Markets may now watch for further announcements from Zydus regarding its US business plans. *Disclaimer: For informational purposes only, not investment advice.*